New Drug Target for Acute Myeloid Leukaemia

News   Nov 28, 2017 | Original story from Wellcome Trust Sanger Institute

 
New Drug Target for Acute Myeloid Leukaemia

Acute myeloid leukamia (AML) cells. Genomic research has found that AML cannot survive without the METTL3 gene, making it a strong therapeutic target. Image credit: The Armed Forces Institute of Pathology (AFIP)

 
 
 

RELATED ARTICLES

Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the Body

News

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.

READ MORE

CRISPR Study Reveals Errors in Earlier Cancer Research

News

MELK, a protein previously thought to be implicated in cancer, has been shown to be unrelated to the disease.

READ MORE

Human Malaria Parasites Grown for the First Time in Dormant Form

News

One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE